Physician profile
Sara A Walker
NPI 1740959550
$792.47
in general payments reported to CMS, 2019-2025
15 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.43 · 2024: $407 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503 · Education: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.49 |
| Education | $288.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $188.99 | 2024-2025 | |
| Sobi, INC | $116.06 | 2024 | |
| Janssen Biotech, INC. | $114.40 | 2025 | Rybrevant, Carvykti |
| Astrazeneca Pharmaceuticals LP | $43.81 | 2024-2025 | Lynparza |
| Novartis Pharmaceuticals Corporation | $43.79 | 2025 | |
| Pfizer INC. | $39.21 | 2024 | |
| Daiichi Sankyo INC. | $36.86 | 2024 | Enhertu |
| Amgen INC. | $36.00 | 2023 | Blincyto |
| Genzyme Corporation | $35.59 | 2025 | |
| Abiomed | $35.13 | 2024 | Impella |
| Glaxosmithkline, LLC. | $25.49 | 2025 | Ojjaara |
| Array Biopharma INC | $21.32 | 2024 | Mektovi, Lorbrena, Braftovi |
| Genentech USA, INC. | $20.58 | 2024 | |
| Kite Pharma, INC. | $19.43 | 2023 | |
| Eisai INC. | $15.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.